How Paxlovid came to be; using AI to predict missed appointments

The Paxlovid story is one of pharmaceutical triumph, pieced together from interviews with Pfizer's top researchers and with outside experts. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by   STAT+: How Paxlovid came to be: From the germ of an idea to a vital tool against Covid By Matthew Herper Vanessa Leroy for STAT This is the story of a pharmaceutical triumph, pieced together from interviews with Pfizer’s top researchers and with outside experts. Read More AI can predict missed appointments. How can hospitals use that data for better care? By Mohana Ravindranath Lane Turner/Boston Globe Boston Children's Hospital helped develop a model to predict missed appointments. But it isn't yet sold on taking it out of pilot mode. Read More STAT+: Tough questions, few answers: The FDA wrestles with its approach to AI in medicine By Casey Ross Adobe The FDA put one of its regulatory officers in front of a room full of medical AI experts. They had a slew of questions. Read More Sponsor content by Genmab Four innovations that may shape cancer treatment How are researchers exploring ways to teach the immune system to take on cancer? Can data sciences improve our understanding of cancer as a disease and help create new medicines? We are unraveling four trends that have the potential to move cancer treatment forward, including approaches from the frontiers of science such as immuno-oncology, translational research and data science, and a different way of working together to nurture innovation. Incoming JAMA editor says the journal's issues handling race are 'not unique to JAMA' By Allison DeAngelis STAT "For me, the issues that were so prominent to place JAMA in the news were not surprising," Kirsten Bibbins-Domingo said at a STAT event. Read More How climate change could drive animal movements — and threaten more viral spillovers By Andrew Joseph MENAHEM KAHANA/AFP via Getty Images There could be more than 4,000 new cross-species swapping of viruses by 2070, even if warming is kept within 2 degrees Celsius, a study finds. Read More Moderna seeks to be first with Covid shots for children younger than 6 By Lauran Neergaard — Associated Press NGELA WEISS/AFP via Getty Images Families are waiting impatiently for a chance to protect their kids as all around them people shed masks and other health precautions. Read More FDA issues plan to ban menthol in cigarettes, cigars By Matthew Perrone — Associated Press Jeff Chiu/AP The FDA said eliminating menthol cigarettes could prevent between 300,000 and 650,000 smoking deaths over 40 years. Read More STAT+: With new diabetes drug data, Eli Lilly is taking aim at obesity By Matthew Herper Kristoffer Tripplaar/AP Lilly released new data showing that an injectable diabetes drug it is developing can lead to substantial weight loss in people with obesity. Read More Listen: How cancer-killing cell therapies work, biotech's endless downturn, & an FDA conundrum By Damian Garde and Meg Tirrell and Adam Feuerstein Immunologist Katy Rezvani of MD Anderson Cancer Center joins us to explain the massive potential of a new approach to treating wily tumors. Read More Thursday, April 28, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser